← Leaderboards
Brooke Worster
University Of Pennsylvania
$921,452
Attributed
$2,764,355
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $733.4K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,764,355 · 1
By mechanism
R01$2,764,355 · 1
Top collaborators
- Rebecca Ashare6 shared
- Salimah H. Meghani6 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Salimah H. Meghani$5,248,349
- Anna Rose Childress$14,753,643
- Kyle Matthew Kampman$31,481,891
- Martin D Cheatle$4,807,748
- Beau M Ances$37,924,420
Others in their field
Other Rising Stars on “Guidelines”
- Mari Ostendorf · University Of Washington$51,931,230
- Joon Sup Lee · Emory University$10,751,414
- Colin Osborne · University Of Texas Med Br Galveston$10,407,745
- Kurt Langenbach · Precision Bioservices, Inc.$8,884,583
- Robert C Alexander · Banner Health$8,197,111
- Deborah J Goff · Dana-Farber Cancer Inst$6,540,771
Research focus
GuidelinesMalignant NeoplasmsFrequenciesCohort StudiesHealth SystemInterdisciplinary StudyAdultEnrollmentClinical Practice GuidelineCancer Pain ManagementAdjuvant AnalgesicCancer ScienceCancer TherapyIndexingCannabinoidsCannabisDesignEcological Momentary AssessmentCancer PainAnxietyCharacteristicsClassificationCancer PatientMarijuana Use
Grant awards (6)
Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study$662,839
R01 · FY2025 · CA
Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study$70,531
R01 · FY2025 · CA
Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study$620,322
R01 · FY2024 · CA
Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study$68,605
R01 · FY2024 · CA
Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study$642,629
R01 · FY2023 · CA
Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study$699,429
R01 · FY2022 · CA